Online citations, reference lists, and bibliographies.
← Back to Search

Multicenter Phase II Study Of Trastuzumab In Combination With Epirubicin And Docetaxel As First-line Treatment For HER2-overexpressing Metastatic Breast Cancer

M. Venturini, C. Bighin, S. Monfardini, F. Cappuzzo, N. Olmeo, A. Durando, F. Puglisi, O. Nicoletto, A. Lambiase, L. Del Mastro

Save to my Library
Download PDF
Analyze on Scholarcy
Share